Intellectual Product – Page 2

2025 FDA staff cuts and their impact on new drug review timelines

3 weeks ago talkbio0Tagged 2025, CHARGE Syndrome, Drug Approval, drug review, HHS, layoffs, PDUFA, Programs - Publication Format, regulatory timelines, RFK gene, Staff, TimeLine Fluoride Releasing Resin, United States Food and Drug Administration, user fee, Workforce

FDA layoffs 2025; drug review timelines; user fee programs; HHS staff cuts; RFK Jr. layoffs; PDUFA; regulatory timelines; drug approvals; FDA workforce reductions

OpenAI launches ChatGPT Health as a dedicated, privacy-focused health assistant

4 weeks ago talkbio0Tagged Apple Health, b.well partnership, ChatGPT Health, DNA Integration, Health care facility, health data privacy, HealthBench, Healthcare AI, Medical Records, wellness apps * *

OpenAI; ChatGPT Health; healthcare AI; medical records integration; Apple Health; wellness apps; health data privacy; HealthBench; b.well partnership; AI in healthcare

Alumis’ TYK2 Inhibitor Envudeucitinib Succeeds in Phase 3 Psoriasis Trials, Plans FDA Filing

4 weeks ago talkbio0Tagged Alumis, Approved, envudeucitinib, Phase 3 trials, Psoriasis, Psoriasis Area and Severity Index Clinical Classification, TYK2 Inhibitor, United States Food and Drug Administration

Alumis; envudeucitinib; TYK2 inhibitor; psoriasis; Phase 3 trials; FDA approval; PASI 75

Innovative Solutions for Difficult-to-Express Proteins: Cell-Free Systems and AI-Driven Advances

4 weeks ago talkbio0Tagged AI protein design, Alternative, Cell-free protein, Difficult-to-Express Proteins, Gene Expression, In Vitro [Publication Type]

cell-free protein expression; difficult-to-express proteins; AI protein design; in vitro expression; alternative proteins

Breakthrough Real-World Evidence Powering Blood Cancer Research in 2025

1 month ago talkbio0Tagged Asymmetric Septal Hypertrophy, hematologic care, Hematologic Neoplasms, real-world evidence, Real-world Evidence, SOHO

RWE; blood cancer; real-world evidence; ASH 2025; SOHO 2025; hematologic care

Endpoints News Topics at 2026 JPM Healthcare Conference: CEOs, Investors, China, and Beyond

1 month ago talkbio0Tagged AI healthcare, Biopharma, CEOs, Endpoints, investors, JPM Healthcare Conference, News [Publication Type], Private Equity

JPM Healthcare Conference; Endpoints News; CEOs; investors; AI healthcare; biopharma; private equity

Quantori and Expert Systems Partner to Accelerate Drug Discovery with Foundational Predictive AI Models

1 month ago talkbio0Tagged AI models, Dosage Forms, Drug Discovery, Expert Systems, Q-Scientist, Quantori, R&D

Quantori; Expert Systems; drug discovery; AI models; Q-Scientist; pharmaceutical R&D

Biopharma’s Winners and Losers of 2025 – Endpoints News recap

1 month ago talkbio0Tagged 2025, Biopharma, Endpoints, Kyle LaHucik, Losers, movers, News [Publication Type], Pharma, Post-Hoc Live, Review [Publication Type], winners

Endpoints News; winners and losers; 2025; biopharma; Post-Hoc Live; Kyle LaHucik; year in review; biotech; pharma; stock movers

No public results for “Take the Biopharma Sentiment Index” Q1 2026 yet

1 month ago talkbio0Tagged Attitude, Biological Science Disciplines, Biopharma, biopharma executives, Biopharma Sentiment Index, geopolitical risk, M&A activity, Q1 2026, Sentiment, Surveys

Biopharma Sentiment Index; Q1 2026; biopharma executives; life sciences sentiment; 2026 outlook; M&A activity; AI in biopharma; geopolitical risk; survey data

FDA Advances Real-World Data Use and Early-Phase Trial Reforms to Accelerate Drug Approvals

2 months ago talkbio0Tagged Drug Approval, early-phase trials, real-world data, real-world evidence, Real-world Evidence, RWE, Transplant Registry Unified Management Program, Trump, United States Food and Drug Administration

FDA; real-world data; real-world evidence; RWE; early-phase trials; drug approval; Marty Makary; Trump